MedPath

Ciprofloxacin

Ciprofloxacin Ophthalmic SolutionUSP0.3% as base

Approved
Approval ID

45ff37cf-bb29-4e8b-99b4-881967ef61b3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 27, 2010

Manufacturers
FDA

Pack Pharmaceuticals, LLC

DUNS: 614823875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ciprofloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16571-135
Application NumberANDA077568
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ciprofloxacin
Product Specifications
Route of AdministrationOPHTHALMIC, TOPICAL
Effective DateJuly 27, 2010
FDA Product Classification

INGREDIENTS (8)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
CIPROFLOXACIN HYDROCHLORIDEActive
Quantity: 3 mg in 1 mL
Code: 4BA73M5E37
Classification: ACTIM
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ciprofloxacin - FDA Drug Approval Details